Thyroid News

Patients with noncancerous thyroid nodules may have a new treatment option as Mount Sinai West introduced a radiofrequency ablation procedure in August, according to a press release.

Chinese adults with differentiated thyroid cancer are more likely to have overweight or obesity vs. matched controls without thyroid disease, with a greater risk observed among younger adults, according to findings published in Clinical Endocrinology.

Access to surgery and radioactive iodine therapy for papillary thyroid cancer is greater for adults with private health insurance than for those without insurance, and cancer severity at diagnosis is often less for those with insurance, according to findings published in Thyroid. 

Children with differentiated thyroid cancer may be more likely to develop lymph node metastasis when microscopic extrathyroidal extension, or microETE, is present, according to findings published in Thyroid.

Radioactive iodine therapy and thyroid surgery may be more effective than antithyroid medications in helping adults with Graves’ hyperthyroidism achieve remission, according to findings published in Thyroid.

The FDA on Monday granted priority review of the investigational medication teprotumumab for treatment of thyroid eye disease, also known as Graves’ orbitopathy according to a press release from Horizon Therapeutics.

Endocrine Today has compiled a list of the top 10 news reports posted so far in of 2019.

Each month Endocrine Today reporters delve deep into a topic of current interest. These longform cover stories provide background and insights from leading researchers and clinicians. All of these features can be found under the opinion tab above and at the links below. Stories published so far in 2019 include emerging alternatives in thyroid cancer treatment, promising developments in beta-cell regeneration, questions about vitamin D’s effectiveness, and more.

Thyroid microcarcinomas are more likely than larger cancers to be discovered by ultrasound and less likely to be associated with surgery scheduled for known thyroid cancer, according to findings from a large, population-based study that included patient-reported data.

Pregnant women with thyroid dysfunction exposed to methimazole therapy during the first trimester are more likely to deliver infants with a birth defect diagnosed before age 2 years than women exposed to propylthiouracil or no therapy, according to a large database analysis published in The Journal of Clinical Endocrinology & Metabolism.